Perrigo Israel Pharmaceuticals

FDA Regulatory Profile

Perrigo Israel Pharmaceuticals appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1286-2015, Class III) was initiated on July 13, 2015.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1286-2015Class IIIMometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, July 13, 2015